Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
236.99
+12.11 (5.39%)
Last updated: Mar 28, 2025

SHA:688506 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
5,823560.42701.83794.951,011
Upgrade
Other Revenue
-1.461.451.781.66
Upgrade
Revenue
5,823561.87703.28796.731,013
Upgrade
Revenue Growth (YoY)
936.31%-20.11%-11.73%-21.33%-16.07%
Upgrade
Cost of Revenue
264.39242.26237.7203.39202.02
Upgrade
Gross Profit
5,558319.61465.58593.34810.69
Upgrade
Selling, General & Admin
405.04367.89403.01467.46636.86
Upgrade
Research & Development
1,443746.23375.02278.6195.7
Upgrade
Other Operating Expenses
-33.15-2.279.799.173
Upgrade
Operating Expenses
1,8151,105795.41752.86833.55
Upgrade
Operating Income
3,744-785.6-329.83-159.52-22.85
Upgrade
Interest Expense
--24.68-22.48-8.69-7.57
Upgrade
Interest & Investment Income
19.235.710.773.614.75
Upgrade
Currency Exchange Gain (Loss)
--1.11-0.05-0.14-
Upgrade
Other Non Operating Income (Expenses)
223.17-0.84-0.56-0.350.02
Upgrade
EBT Excluding Unusual Items
3,986-806.51-352.16-165.09-25.66
Upgrade
Gain (Loss) on Sale of Investments
11.44---0.34
Upgrade
Gain (Loss) on Sale of Assets
-0-0.14-0.48-0.45-
Upgrade
Asset Writedown
-19.35----0.17
Upgrade
Other Unusual Items
-37.6463.5761.171.11
Upgrade
Pretax Income
3,978-769.01-289.07-104.4445.62
Upgrade
Income Tax Expense
270.6511.49-6.69-4.457.7
Upgrade
Earnings From Continuing Operations
3,708-780.5-282.38-99.9937.92
Upgrade
Minority Interest in Earnings
-----0.02
Upgrade
Net Income
3,708-780.5-282.38-99.9937.9
Upgrade
Net Income to Common
3,708-780.5-282.38-99.9937.9
Upgrade
Net Income Growth
----390.26%
Upgrade
Shares Outstanding (Basic)
401400362357345
Upgrade
Shares Outstanding (Diluted)
401400362357345
Upgrade
Shares Change (YoY)
0.14%10.56%1.38%3.64%-10.86%
Upgrade
EPS (Basic)
9.25-1.95-0.78-0.280.11
Upgrade
EPS (Diluted)
9.25-1.95-0.78-0.280.11
Upgrade
EPS Growth
----450.00%
Upgrade
Free Cash Flow
3,975-697.29-293.21-179.6363.09
Upgrade
Free Cash Flow Per Share
9.92-1.74-0.81-0.500.18
Upgrade
Gross Margin
95.46%56.88%66.20%74.47%80.05%
Upgrade
Operating Margin
64.29%-139.82%-46.90%-20.02%-2.26%
Upgrade
Profit Margin
63.67%-138.91%-40.15%-12.55%3.74%
Upgrade
Free Cash Flow Margin
68.26%-124.10%-41.69%-22.55%6.23%
Upgrade
EBITDA
3,812-727.7-272.27-109.3726.45
Upgrade
EBITDA Margin
65.46%-129.51%-38.71%-13.73%2.61%
Upgrade
D&A For EBITDA
68.0357.957.5650.1649.31
Upgrade
EBIT
3,744-785.6-329.83-159.52-22.85
Upgrade
EBIT Margin
64.29%-139.82%-46.90%-20.02%-2.26%
Upgrade
Effective Tax Rate
6.80%---16.87%
Upgrade
Revenue as Reported
-561.87703.28796.731,013
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.